Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 3Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Melanoma 8Uveal Melanoma 3Carcinoma, Ovarian Epithelial 2Ovarian Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mesothelioma, Malignant 1Lung Neoplasms 1Leukemia, Plasma Cell 1Leukemia 1Fallopian Tube Neoplasms 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adenoma, Islet Cell 1

Interventions

Ipilimumab 10Nivolumab 9Interleukin-2 5Cyclophosphamide 5pembrolizumab 3incomplete Freund's adjuvant 3fludarabine phosphate 3Radiosurgery 3Melphalan 3ADI PEG20 3sotrastaurin 2fludarabine 2Specimen Handling 2Ranibizumab 2Magnetic Resonance Spectroscopy 2MART-1 Antigen 2CTLA-4 Antigen 2Biopsy 2utomilumab 1tocilizumab 1siremadlin 1sargramostim 1ruxolitinib 1relatlimab 1pentetreotide 1obinutuzumab 1montanide ISA 51 1lifileucel 1gp100 Melanoma Antigen 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Uveal Melanoma × incomplete Freund's adjuvant × Clear all
NCT00705640 2016-12-16

Mel48

University of Virginia

Phase 1 Completed
45 enrolled
Dermatologic

Uveal Melanoma, Melanoma

NCT00005841 2014-05-22

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

University of Southern California

Phase 1 Terminated
15 enrolled
Dermatologic

Uveal Melanoma, Melanoma

NCT00025181 2014-05-22

Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

University of Southern California

Phase 1 Completed
19 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡